Evaxion A EVAX
NASDAQ EVAX
$4.21 +0.16 (+3.95%)
As of: Oct 21, 2026 · 10:50 AM EDT

Evaxion A (EVAX) Net Margin (2023 - 2025)

Updated

Evaxion A (EVAX) recorded Net Margin of -102.38% in FY2025, up 213.62 percentage points from -316.00% in FY2024.

Analysis

Evaxion A (EVAX) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, EVAX's Net Margin was -316.00% in FY2024 (+29992.22 pp) and -30308.22% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn 21.86%
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 21.27%
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn 16.30%
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn -134.51%
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn -1.65%
10 Evaxion A 27.03 Mn -39.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 61.64%
Jun 30, 2025 -13,056.76%
Dec 31, 2024 -2,974.59%
Sep 30, 2024 -64.14%
Jun 30, 2024 -4,024.68%
Mar 31, 2024 2,341.18%
Dec 31, 2023 -610.39%
API Access

Evaxion A Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY